SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-16-017048
Filing Date
2016-04-29
Accepted
2016-04-29 06:01:59
Documents
5
Period of Report
2016-06-23
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A atra-def14a_20160623.htm DEF 14A 1060910
2 GRAPHIC gyqkw3i2loeg000004.jpg GRAPHIC 59764
3 GRAPHIC gyqkw3i2loeg000001.jpg GRAPHIC 1951
4 GRAPHIC gyqkw3i2loeg000003.jpg GRAPHIC 109644
5 GRAPHIC gyqkw3i2loeg000002.jpg GRAPHIC 1951
  Complete submission text file 0001564590-16-017048.txt   1301257
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36548 | Film No.: 161602330
SIC: 2836 Biological Products, (No Diagnostic Substances)